Jeff Love1, Douglas Zatzick1. 1. The authors are with the Department of Psychiatry and Behavioral Sciences, Harborview Medical Center, University of Washington, Seattle. Send correspondence to Dr. Zatzick (e-mail: dzatzick@u.washington.edu). A preliminary version of this paper was presented at the annual meeting of the American Psychiatric Association, San Francisco, May 18-22, 2013.
Abstract
OBJECTIVE: Few investigations have examined screening and intervention procedures for comorbid substance use and mental disorders at trauma centers in the United States, although these disorders are endemic among survivors of traumatic injury. In 2006, the American College of Surgeons (ACS) mandated that level I and level II trauma centers screen for alcohol use problems and that level I centers provide brief intervention for those who screen positive. The ACS is expected to recommend best practice policy guidelines for screening for drug use problems and posttraumatic stress disorder (PTSD). This study examined screening and intervention procedures for the full spectrum of comorbid mental and substance use disorders at U.S. trauma centers. METHODS: Respondents at all level I and level II trauma centers (N=518) in the United States were asked to complete a survey describing screening and intervention procedures for alcohol and drug use problems, suicidality, depression, and PTSD. RESULTS: There were 391 (75%) respondents. Over 80% of trauma centers routinely screened for alcohol and drug use problems. Routine screening and intervention for suicidality, depression, and PTSD were markedly less common; in fact, only 7% of centers reported routine screening for PTSD. Consistent with ACS policy, level I centers were significantly more likely than level II centers to provide alcohol intervention. CONCLUSIONS: Alcohol screening and intervention occurred frequently at U.S. trauma centers and appeared to be responsive to ACS mandates. In the future, efforts to orchestrate clinical investigation and policy could enhance screening and intervention procedures for highly prevalent, comorbid mental disorders.
OBJECTIVE: Few investigations have examined screening and intervention procedures for comorbid substance use and mental disorders at trauma centers in the United States, although these disorders are endemic among survivors of traumatic injury. In 2006, the American College of Surgeons (ACS) mandated that level I and level II trauma centers screen for alcohol use problems and that level I centers provide brief intervention for those who screen positive. The ACS is expected to recommend best practice policy guidelines for screening for drug use problems and posttraumatic stress disorder (PTSD). This study examined screening and intervention procedures for the full spectrum of comorbid mental and substance use disorders at U.S. trauma centers. METHODS: Respondents at all level I and level II trauma centers (N=518) in the United States were asked to complete a survey describing screening and intervention procedures for alcohol and drug use problems, suicidality, depression, and PTSD. RESULTS: There were 391 (75%) respondents. Over 80% of trauma centers routinely screened for alcohol and drug use problems. Routine screening and intervention for suicidality, depression, and PTSD were markedly less common; in fact, only 7% of centers reported routine screening for PTSD. Consistent with ACS policy, level I centers were significantly more likely than level II centers to provide alcohol intervention. CONCLUSIONS:Alcohol screening and intervention occurred frequently at U.S. trauma centers and appeared to be responsive to ACS mandates. In the future, efforts to orchestrate clinical investigation and policy could enhance screening and intervention procedures for highly prevalent, comorbid mental disorders.
Authors: Douglas Zatzick; Gregory J Jurkovich; Frederick P Rivara; Jin Wang; Ming-Yu Fan; Jutta Joesch; Ellen Mackenzie Journal: Ann Surg Date: 2008-09 Impact factor: 12.969
Authors: C A Soderstrom; G S Smith; P C Dischinger; D R McDuff; J R Hebel; D A Gorelick; T J Kerns; S M Ho; K M Read Journal: JAMA Date: 1997-06-11 Impact factor: 56.272
Authors: L M Gentilello; F P Rivara; D M Donovan; G J Jurkovich; E Daranciang; C W Dunn; A Villaveces; M Copass; R R Ries Journal: Ann Surg Date: 1999-10 Impact factor: 12.969
Authors: Francine Terrell; Douglas F Zatzick; Gregory J Jurkovich; Frederick P Rivara; Dennis M Donovan; Christopher W Dunn; Carol Schermer; Jay Wayne Meredith; Larry M Gentilello Journal: J Am Coll Surg Date: 2008-07-14 Impact factor: 6.113
Authors: Rajeev Ramchand; Grant N Marshall; Terry L Schell; Lisa H Jaycox; Katrin Hambarsoomians; Vivek Shetty; Gudata S Hinika; H Gill Cryer; Peter Meade; Howard Belzberg Journal: J Trauma Date: 2009-05
Authors: Douglas F Zatzick; Frederick P Rivara; Avery B Nathens; Gregory J Jurkovich; Jin Wang; Ming-Yu Fan; Joan Russo; David S Salkever; Ellen J Mackenzie Journal: Psychol Med Date: 2007-06-11 Impact factor: 7.723
Authors: Douglas Zatzick; Peter Roy-Byrne; Joan Russo; Frederick Rivara; RoseAnne Droesch; Amy Wagner; Chris Dunn; Gregory Jurkovich; Edwina Uehara; Wayne Katon Journal: Arch Gen Psychiatry Date: 2004-05
Authors: Brian E Bunnell; Tatiana M Davidson; Jennifer R Winkelmann; Jessica L Maples-Keller; Leigh E Ridings; Jennifer Dahne; Samir M Fakhry; Kenneth J Ruggiero Journal: Telemed J E Health Date: 2019-02-07 Impact factor: 3.536
Authors: Therese S Richmond; Douglas J Wiebe; Patrick M Reilly; John Rich; Justine Shults; Nancy Kassam-Adams Journal: JAMA Surg Date: 2019-09-01 Impact factor: 14.766
Authors: Kenneth J Ruggiero; Tatiana M Davidson; Margaret T Anton; Brian Bunnell; Jennifer Winkelmann; Leigh E Ridings; Olivia Bravoco; Bruce Crookes; James McElligott; Samir M Fakhry Journal: J Am Coll Surg Date: 2020-04-23 Impact factor: 6.113